elsubrutinib
Showing 1 - 3 of 3
Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)
Terminated
- Rheumatoid Arthritis (RA)
- Elsubrutinib
- +3 more
-
Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
- +29 more
Aug 18, 2021
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Elsubrutinib, Placebo for Elsubrutinib, Upadacitinib)
Completed
- Systemic Lupus Erythematosus (SLE)
- Elsubrutinib
- +3 more
-
Mesa, Arizona
- +159 more
Dec 19, 2022
Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)
Completed
- Rheumatoid Arthritis (RA)
- Elsubrutinib
- +3 more
-
Huntsville, Alabama
- +114 more
Apr 6, 2021